|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.72 CNY | -0.82% |
|
-1.44% | +4.31% |
| 07-20 | Tasly Pharmaceutical Gets China Greenlight for Stroke Drug Trial | MT |
| 07-14 | Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 23.48B 3.48B 3.01B 2.81B 2.58B 4.88B 331B 4.93B 33B 12.95B 166B 13.07B 12.78B 548B | P/E 2026 * |
17.5x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 22.23B 3.29B 2.85B 2.66B 2.44B 4.62B 313B 4.67B 31.23B 12.26B 157B 12.36B 12.09B 519B | EV / Sales 2026 * |
2.47x | EV / Sales 2027 * | 1.81x |
| Free-Float |
47.15% | Yield 2026 * |
2.86% | Yield 2027 * | 3.27% |
| 1 day | -0.82% | ||
| 1 week | -1.44% | ||
| Current month | -2.48% | ||
| 1 month | +12.29% | ||
| 3 months | +3.90% | ||
| 6 months | +4.66% | ||
| Current year | +4.31% |
| 1 week | 15.58 |  | 16.22 |
| 1 month | 13.78 | | 16.24 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 17.69 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 07/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 08/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 30/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 01/06/2021 |
Jin Yong Cai
BRD | Director/Board Member | 54 | 24/03/2006 |
Ke Xin Li
BRD | Director/Board Member | 58 | 07/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.82% | -1.44% | -4.96% | +12.93% | 3.48B | |
| -1.55% | -1.91% | -9.40% | -6.00% | 13.45B | |
| -2.68% | -3.09% | -32.09% | -54.39% | 5.09B | |
| -0.64% | +0.84% | +5.03% | +8.07% | 5.13B | |
| -2.08% | -1.67% | +0.49% | -33.25% | 4.07B | |
| -1.35% | -2.10% | -7.35% | -4.11% | 3.7B | |
| -0.61% | -2.60% | -2.67% | +4.67% | 3.58B | |
| -0.89% | +0.19% | -14.80% | -23.12% | 2.45B | |
| -1.53% | -2.85% | -3.23% | +49.80% | 1.87B | |
| -1.25% | -0.39% | -36.04% | -14.10% | 1.73B | |
| Average | -1.34% | -2.28% | -10.50% | -5.95% | 4.46B | |
| Weighted average by Cap. | -1.43% | -2.62% | -9.44% | -8.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9B 1.33B 1.15B 1.08B 990M 1.87B 127B 1.89B 12.64B 4.96B 63.41B 5.01B 4.9B 210B | 9.78B 1.45B 1.26B 1.17B 1.08B 2.03B 138B 2.05B 13.75B 5.4B 68.95B 5.44B 5.32B 228B |
| Net income | 1.36B 202M 175M 163M 150M 283M 19.17B 286M 1.91B 751M 9.59B 757M 741M 31.77B | 1.61B 238M 206M 192M 177M 334M 22.65B 338M 2.26B 887M 11.33B 895M 875M 37.53B |
| Net Debt | -1.26B -186M -161M -151M -138M -261M -17.73B -264M -1.77B -694M -8.87B -700M -685M -29.38B | -5.78B -856M -741M -691M -635M -1.2B -81.36B -1.21B -8.12B -3.19B -40.71B -3.21B -3.14B -135B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | CN¥15.72 | -0.82% | 15,527,080 |
| 04/08/26 | CN¥15.85 | -0.31% | 14,918,692 |
| 03/08/26 | CN¥15.90 | -1.36% | 16,376,039 |
| 31/07/26 | CN¥16.12 | +1.51% | 21,670,879 |
| 30/07/26 | CN¥15.88 | -0.44% | 17,778,996 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
